Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
Blood Advances|September 8, 2019
Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70Philip H Imus, Hua-Ling Tsai, Leo Luznik, et al.Journal of Neuro-Oncology|July 20, 2002
An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitisKurt A Jaeckle, Tracy Batchelor, Steven J O'Day, et al.Blood Advances|April 29, 2020
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamideAmy E DeZern, Marianna L Zahurak, Heather J Symons, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2015
Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA FactorsJennifer A Kanakry, Christopher D Gocke, Javier Bolaños-Meade, et al.Transplantation and Cellular Therapy|July 22, 2021
Allogeneic Blood or Marrow Transplantation with Nonmyeloablative Conditioning and High-Dose Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis for Secondary Central Nervous System LymphomaCole H Sterling, Hua-Ling Tsai, Matthias Holdhoff, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 2, 2019
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant CyclophosphamideShannon R McCurdy, Christopher G Kanakry, Hua-Ling Tsai, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2020
Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation CyclophosphamideAmy E DeZern, Hany Elmariah, Marianna Zahurak, et al.Transplantation and Cellular Therapy|August 23, 2021
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation CyclophosphamideKatherine C Rappazzo, Marianna Zahurak, Maria Bettinotti, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2020
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease ProphylaxisPhilip H Imus, Hua-Ling Tsai, Amy E DeZern, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 9, 2019
Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell TransplantationPhilip H Imus, Amanda L Blackford, Maria Bettinotti, et al.Pageof 8